BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23137697)

  • 1. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
    Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
    Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory deficits in the transgenic rat model of Huntington's disease.
    Zeef DH; van Goethem NP; Vlamings R; Schaper F; Jahanshahi A; Hescham S; von Hörsten S; Prickaerts J; Temel Y
    Behav Brain Res; 2012 Feb; 227(1):194-8. PubMed ID: 22101303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
    Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance.
    Brooks S; Fielding S; Döbrössy M; von Hörsten S; Dunnett S
    Brain Res Bull; 2009 Jun; 79(5):310-5. PubMed ID: 19480990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
    J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG
    Stefanko DP; Shah VD; Yamasaki WK; Petzinger GM; Jakowec MW
    Neurobiol Dis; 2017 Sep; 105():15-32. PubMed ID: 28502806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease.
    Faure A; Höhn S; Von Hörsten S; Delatour B; Raber K; Le Blanc P; Desvignes N; Doyère V; El Massioui N
    Neurobiol Learn Mem; 2011 Jan; 95(1):92-101. PubMed ID: 21111837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.
    Pang TYC; Stam NC; Nithianantharajah J; Howard ML; Hannan AJ
    Neuroscience; 2006 Aug; 141(2):569-584. PubMed ID: 16716524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.
    Nguyen HP; Kobbe P; Rahne H; Wörpel T; Jäger B; Stephan M; Pabst R; Holzmann C; Riess O; Korr H; Kántor O; Petrasch-Parwez E; Wetzel R; Osmand A; von Hörsten S
    Hum Mol Genet; 2006 Nov; 15(21):3177-94. PubMed ID: 16984963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease.
    Casteels C; Vandeputte C; Rangarajan JR; Dresselaers T; Riess O; Bormans G; Maes F; Himmelreich U; Nguyen H; Van Laere K
    Exp Neurol; 2011 Jun; 229(2):440-9. PubMed ID: 21459091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease.
    Abada YS; Nguyen HP; Ellenbroek B; Schreiber R
    PLoS One; 2013; 8(11):e71633. PubMed ID: 24223692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
    Yu-Taeger L; Petrasch-Parwez E; Osmand AP; Redensek A; Metzger S; Clemens LE; Park L; Howland D; Calaminus C; Gu X; Pichler B; Yang XW; Riess O; Nguyen HP
    J Neurosci; 2012 Oct; 32(44):15426-38. PubMed ID: 23115180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease.
    Urbach YK; Raber KA; Canneva F; Plank AC; Andreasson T; Ponten H; Kullingsjö J; Nguyen HP; Riess O; von Hörsten S
    J Neurosci Methods; 2014 Aug; 234():38-53. PubMed ID: 25020253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.
    Ciamei A; Morton AJ
    Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.
    van Oostrom JC; Dekker M; Willemsen AT; de Jong BM; Roos RA; Leenders KL
    Eur J Neurol; 2009 Feb; 16(2):226-31. PubMed ID: 19138335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease.
    Fielding SA; Brooks SP; Klein A; Bayram-Weston Z; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):223-36. PubMed ID: 21963415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain.
    Giménez-Llort L; Schiffmann SN; Shmidt T; Canela L; Camón L; Wassholm M; Canals M; Terasmaa A; Fernández-Teruel A; Tobeña A; Popova E; Ferré S; Agnati L; Ciruela F; Martínez E; Scheel-Kruger J; Lluis C; Franco R; Fuxe K; Bader M
    Neurobiol Learn Mem; 2007 Jan; 87(1):42-56. PubMed ID: 16824773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.
    Kandasamy M; Rosskopf M; Wagner K; Klein B; Couillard-Despres S; Reitsamer HA; Stephan M; Nguyen HP; Riess O; Bogdahn U; Winkler J; von Hörsten S; Aigner L
    PLoS One; 2015; 10(2):e0116069. PubMed ID: 25719447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.